Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Addition of Spironolactone in Patients With Resistant Arterial Hypertension

NCT00524615 is registered in ClinicalTrials.gov with Jan Vaclavík as lead sponsor.

NCT NCT00524615
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00524615 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Addition of Spironolactone in Patients With Resistant Arterial Hypertension
Lead sponsor
Jan Vaclavík
Phase
Phase 4
Overall status
Unknown status
Start date
September 30, 2007
Completion date
December 31, 2012
Enrollment
160 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension